[{"address1": "333 Las Olas Way", "address2": "CU4 Suite 433", "city": "Fort Lauderdale", "state": "FL", "zip": "33301", "country": "United States", "phone": "(954) 330-0684", "website": "https://sunshinebiopharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sunshine Biopharma, Inc. operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates through Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products segments. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.", "fullTimeEmployees": 52, "companyOfficers": [{"maxAge": 1, "name": "Dr. Steve N. Slilaty Ph.D.", "age": 72, "title": "Chairman, President & CEO", "yearBorn": 1952, "fiscalYear": 2024, "totalPay": 1291587, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Camille  Sebaaly", "age": 65, "title": "CFO & Secretary", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 352031, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Abderrazzak  Merzouki", "age": 60, "title": "COO & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 366625, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Malek  Chamoun", "age": 39, "title": "Chief Development Officer", "yearBorn": 1985, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michel  Roy", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert G. Ferreira", "age": 62, "title": "President of Sunshine Bio Investments Inc", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.4, "open": 1.37, "dayLow": 1.37, "dayHigh": 1.44, "regularMarketPreviousClose": 1.4, "regularMarketOpen": 1.37, "regularMarketDayLow": 1.37, "regularMarketDayHigh": 1.44, "payoutRatio": 0.0, "beta": 1.235, "forwardPE": 0.0072072074, "volume": 60862, "regularMarketVolume": 60862, "averageVolume": 1434368, "averageVolume10days": 128570, "averageDailyVolume10Day": 128570, "bid": 1.02, "ask": 1.76, "bidSize": 2, "askSize": 2, "marketCap": 6560554, "fiftyTwoWeekLow": 1.169, "fiftyTwoWeekHigh": 15.18, "priceToSalesTrailing12Months": 0.18812011, "fiftyDayAverage": 1.5939, "twoHundredDayAverage": 2.50104, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -5147095, "profitMargins": -0.14722, "floatShares": 2484792, "sharesOutstanding": 4555940, "sharesShort": 395540, "sharesShortPriorMonth": 141279, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.1088, "heldPercentInsiders": 0.03968, "heldPercentInstitutions": 0.10356, "shortRatio": 0.1, "shortPercentOfFloat": 0.1088, "impliedSharesOutstanding": 4555940, "bookValue": 9.103, "priceToBook": 0.15818962, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -5134116, "trailingEps": -5.76, "forwardEps": 199.8, "lastSplitFactor": "1:20", "lastSplitDate": 1723075200, "enterpriseToRevenue": -0.148, "enterpriseToEbitda": 0.921, "52WeekChange": -0.8964029, "SandP52WeekChange": 0.09362543, "quoteType": "EQUITY", "currentPrice": 1.44, "targetHighPrice": 140.0, "targetLowPrice": 140.0, "targetMeanPrice": 140.0, "targetMedianPrice": 140.0, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 9686529, "totalCashPerShare": 3.578, "ebitda": -5588594, "totalDebt": 952480, "quickRatio": 2.146, "currentRatio": 4.112, "totalRevenue": 34874284, "debtToEquity": 4.053, "revenuePerShare": 49.696, "returnOnAssets": -0.12546, "returnOnEquity": -0.22966999, "grossProfits": 10669794, "freeCashflow": -12389965, "operatingCashflow": -12531180, "revenueGrowth": 0.249, "grossMargins": 0.30595, "ebitdaMargins": -0.16025, "operatingMargins": -0.21237, "financialCurrency": "USD", "symbol": "SBFM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Sunshine Biopharma Inc.", "exchange": "NCM", "messageBoardId": "finmb_78729055", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 2.8571486, "regularMarketPrice": 1.44, "corporateActions": [], "postMarketTime": 1748043838, "regularMarketTime": 1748030401, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1644935400000, "postMarketChangePercent": -0.694452, "postMarketPrice": 1.43, "postMarketChange": -0.0100001, "regularMarketChange": 0.04000008, "regularMarketDayRange": "1.37 - 1.44", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1434368, "fiftyTwoWeekLowChange": 0.27100003, "fiftyTwoWeekLowChangePercent": 0.23182209, "fiftyTwoWeekRange": "1.169 - 15.18", "fiftyTwoWeekHighChange": -13.74, "fiftyTwoWeekHighChangePercent": -0.9051383, "fiftyTwoWeekChangePercent": -89.64029, "dividendDate": 1586131200, "earningsTimestamp": 1747339200, "earningsTimestampStart": 1755201600, "earningsTimestampEnd": 1755547200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -5.76, "epsForward": 199.8, "fiftyDayAverageChange": -0.15389991, "fiftyDayAverageChangePercent": -0.09655556, "twoHundredDayAverageChange": -1.0610399, "twoHundredDayAverageChangePercent": -0.4242395, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2022-02-15", "averageAnalystRating": "1.0 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "longName": "Sunshine Biopharma, Inc.", "displayName": "Sunshine Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-05-24"}]